z-logo
open-access-imgOpen Access
ENHANCEMENT OF PHYTOHEMAGGLUTININ‐INDUCED DNA SYNTHESIS OF MOUSE THYMOCYTES AND T‐LYMPHOCYTES BY A NEUTRAL PROTEASE OF POLYMORPHONUCLEAR LEUKOCYTES
Author(s) -
Yoshinaga Masaru,
Nakamura Shuji,
Higuchi Shigenori
Publication year - 1977
Publication title -
acta patholigica japonica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.73
H-Index - 74
ISSN - 0001-6632
DOI - 10.1111/j.1440-1827.1977.tb03040.x
Subject(s) - neutral protease , immunology , protease , dna , dna synthesis , microbiology and biotechnology , chemistry , biology , pathology , medicine , enzyme , biochemistry
Mouse thymocytes were poorly triggered in vitro with phytohemagglutinin (PHA) to induce DNA synthesis and the response was markedly enhanced by culture supernatant (SUP) of polymorphonuclear leukocytes (PMN). The PMN factor was nondialysable, heat‐labile and precipitated with 65% ammonium sulphate. Its molecular weight was approximately 19,000 on sephadex G‐75. The sephadex fraction had a proteolytic activity on 3H‐acetyl hemoglobin at neutral pH. The protease seemed to be a chymotrypsin‐like enzyme on the basis of inhibition profile using various protease inhibitors. The thymocyte‐helping activity in the protease fraction was absorbed by affinity columns of protease inhibitors. The PMN‐protease also enhanced the DNA synthesis by antigen‐stimulated lymph node cells and by PHA‐stimulated T‐lymphocytes, but not by LPS‐stimulated B‐lymphocytes. Only the lymphocytes already been stimulated with antigen or mitogen received preferentially the helping action by PMN‐protease. The helping activity was effectively absorbed by PHA‐stimulated thymocytes but not by nonstimulated thymocytes. These evidences seems to suggest that acceptor sites for the protease, newly developed on lymphocyte surface after stimulation, may play an important role in the enhanced DNA synthetic response. ACTA PATH. JAP. 27: 857‐868, 1977.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here